Short-Acting Insulin Market: Trends, Growth Drivers, and Forecast to 2030
The Global Market For Short-Acting Insulin will reach USD 10287.9 Million by 2030, expanding at a CAGR of 1.18% from USD 9257.1 Million in 2021. The market for rapid-acting insulin is dominated by Sanofi, Novo Nordisk, and Eli Lilly, each with a strong brand presence. However, intense competition requires significant effort to access local markets, prompting these companies […]